UMB Bank’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
UMB Bank's RARE Position: Q3 2026 in Review
UMB Bank sold out of Ultragenyx Pharmaceutical (RARE) in Q3 2026, closing a stake of 494 shares — an estimated $16.5K sold.
UMB Bank first reported a position in RARE in Q2 2023 and held it in 13 quarters. The position peaked at $57.4K in Q3 2024. 266 funds tracked by Wall St. Rank hold RARE as of Q3 2026.
- UMB Bank reported no remaining Ultragenyx Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- UMB Bank sold 494 Ultragenyx Pharmaceutical shares in Q3 2026, an estimated $16.5K.
- UMB Bank first reported a position in Ultragenyx Pharmaceutical in Q2 2023 and held it in 13 quarters.
- UMB Bank's Ultragenyx Pharmaceutical position peaked at $57.4K in Q3 2024.
- 266 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.
Based on UMB Bank's 13F filing for Q3 2026, filed 6 Nov 2026.